Annual feature celebrates graduating business students for achievement and influence

SAN FRANCISCO, May 3, 2025 /PRNewswire/ — Poets&Quants, the leading news source for graduate business education, has released its 11th annual Best & Brightest MBAs feature, which honors 100 of the most accomplished full-time MBAs from the Class of 2025.

“This year’s class could be described as more female and more international, with a stronger military presence,” says Jeff Schmitt, Poets&Quants’ senior writer, who launched the series in 2015. “What really distinguished Best & Brightest students this year was that they built things. They launched ventures early in their careers or started clubs or events at their business schools. They weren’t trying to maintain what already existed or follow the usual paths. They were creating something new – and they provided others with enrichment and opportunities as a result.”

This 2025 class features MBA graduates including Wharton School’s Simi Shah, a successful entrepreneur who has been invited to the White House twice and made the 2025 Forbes “30 Under 30” in Media. Mark O’Connell, a graduate of the University of Michigan’s Ross School, helped re-write the U.S. Maines combat training curriculum – and Ohio State’s Kyle Schembechler did the same for the U.S. Field Artillery School. At the University of Virginia’s Darden School, Amanda Golden has transitioned from covering the 2020 presidential election for NBC News to becoming a venture capitalist. By the same token, Evan Rizvi made the leap from opera singer to strategist at Boston University’s Questrom School.

To compile this year’s Best & Brightest MBAs, Poets&Quants reached out to 82 top graduate business schools worldwide to nominate their best candidates for the honor. Responses were judged by P&Q editorial according to four criteria: extracurricular involvement, academic and professional achievements, insightful responses, and faculty recommendations. Ultimately, P&Q received 220 nominations, including submissions from elite institutions ranging from INSEAD to the University of Chicago’s Booth School. By gender, Best & Brightest women outnumber men by a 60-to-40 margin, with 54 students hailing from outside the United States. The Boston Consulting Group also hired 8 Best & Brightest MBAs from the Class of 2025, the most of any employer.

As part of this feature, each MBA receives an in-depth profile, which covers subjects ranging from their proudest achievement to their favorite business movie. Over the coming months, Best & Brightest will also spotlight the best student responses related topics like their favorite faculty members, biggest school myths, and most interesting school traditions. 

The “Best & Brightest MBAs” is the second of a four-part series recognizing the world’s top business students. In April, Poets&Quants For Undergrads unveiled its 100 Best & Brightest Undergraduate Business Majors of 2025. This summer, Poets&Quants will also recognize its “Best & Brightest Executive MBAs” and “Best & Brightest Online MBAs.” In the fall, P&Q will continue its “Meet the Class” series that highlights the top incoming full-time MBA students at over 40 top business schools.

To read about the “100 Best & Brightest MBAs: Class of 2025”, CLICK HERE.

Poets&Quants, a part of Times Higher Education, is the leading resource for complete coverage of graduate business education. We feature multiple tools and authoritative content, including consolidated business school rankings, news and in-depth features, videos, podcasts, searchable directories, and events, empowering our community with information needed to make decisions along their journey from pre- to post-MBA.

Media Contact: Sat Sharma
Chief Revenue Officer
Poets & Quants
(917) 763-4088

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/poetsquants-names-best–brightest-mbas-of-2025-302445430.html

SOURCE Poets&Quants

STOCKHOLM, May 3, 2025 /PRNewswire/ — At this week’s ESTRO conference in Vienna, RaySearch Laboratories AB (publ) and Vision RT proudly announces the next step in their collaboration: the full integration of MapRT with RayStation®* treatment planning system. This integration enables full access to the MapRT clearance map in RayStation to guide the user during treatment planning in choosing beam trajectories clear from collisions between the treatment unit, patient and couch.

During CT simulation, MapRT cameras capture the entire surface of the patient, along with any immobilization accessories. The MapRT software then analyzes this data, alongside models of the treatment couch and machine, to identify safe gantry and couch angles which are represented by a clearance map that is immediately accessible in RayStation.

The integration is designed to optimize beam options for better plans and minimize the need for dry runs. This is particularly important for treatment plans where the couch is rotated. Recent studies have demonstrated that non-coplanar treatments can significantly improve treatment plans for several cancers, including lung1,2,3,4, breast5,6,7,8, head and neck cancers9,10,11,12,13, lymphoma14,15, and high-grade glioma16. These treatments can offer clinically relevant benefits, such as improved organ-at-risk dose sparing.

Helen Convery, Senior Dosimetrist (Development & Clinical Trials), who has tested the integration, says: “We have used MapRT at Raigmore Hospital since 2022 and have found it invaluable for checking for collision on all plans and optimizing non-coplanar plan angles. I think the integration into RayStation is of significant value and I can see it further streamlining and improving the efficiency of our workflow.”

Thomas Carter, VP of Marketing, Vision RT, adds: “We are already seeing clinics changing their planning techniques, allowing their patients to benefit from the extra beam options MapRT provides. This integration has the potential to streamline workflows, reduce errors, and free up resources, all while improving treatment predictability. It also opens the path for automated, collision-free planning.”

Björn Hårdemark, Deputy CEO, RaySearch: “Surface scanning is an excellent source of information about the most central aspect of radiation therapy – the patient. The tight integration between MapRT and RayStation makes this information available already during treatment planning, allowing the user to explore more creative beam configurations while maintaining clearance around the patient. It is a great example of how clinical benefit can be achieved through collaboration between radiation therapy technology vendors.”

MapRT is approved for CE marking and clinical distribution in the EU and UK. A version without the API is currently cleared for sale in the USA, with API version 510(k) pending.

About Vision RT
Vision RT is the inventor of Surface Guided Radiation Therapy (SGRT) which uses camera systems to track surface data, to offer more guidance across every step of the radiotherapy workflow: simulation, planning, treatment and dose visualization. We work tirelessly to improve the accuracy, efficiency, safety and comfort of radiation therapy.

Vision RT is part of the William Demant Invest (WDI) family, a leading Danish Medtech investor with a long-term investment perspective. The companies in WDI employ more than 21,000 people.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.

RaySearch’s software has been sold to over 1,100 clinics in 47 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.

About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.

* Subject to regulatory clearance in some markets.

Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00 
johan.lof@raysearchlabs.com  

Learn more about us on:
LinkedIn
YouTube

[1] Ma M, Ren W, Li M, Niu C, Dai J. Dosimetric comparison of coplanar and non-coplanar beam arrangements for radiotherapy of patients with lung cancer: A meta-analysis. J Appl Clin Med Phys. 2021 Apr;22(4):34-43. doi: 10.1002/acm2.13197. Epub 2021 Feb 26. PMID: 33634946; PMCID: PMC8035566.

[2] Kim ST, An HJ, Kim JI, Yoo JR, Kim HJ, Park JM. Non-coplanar VMAT plans for lung SABR to reduce dose to the heart: a planning study. Br J Radiol. 2020 Jan;93(1105):20190596. doi: 10.1259/bjr.20190596. Epub 2019 Oct 22. PMID: 31625759; PMCID: PMC6948076.

[3] Lincoln JD, MacDonald RL, Syme A, Thomas CG. Static couch non-coplanar arc selection optimization for lung SBRT treatment planning. Phys Med Biol. 2023 Jul 21;68(15). doi: 10.1088/1361-6560/ace23f. PMID: 37369237.

[4]Chapet O, Khodri M, Jalade P, N’guyen D, Flandin I, D’hombres A, Romestaing P, Mornex F. Potential benefits of using non-coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes. Radiother Oncol. 2006 Sep;80(3):333-40. doi: 10.1016/j.radonc.2006.07.009. Epub 2006 Aug 24. PMID: 16934354.

[5] J, F., et al. (2023). Locoregional breast radiotherapy including IMN: optimizing the dose distribution using an automated non-coplanar VMAT-technique. Acta oncologica (Stockholm, Sweden), [online] 62(10). doi:https://doi.org/10.1080/0284186X.2023.2264488.

[6] Xu, Y., Ma, P., Hu, Z., Tian, Y., Men, K., Wang, S., Xu, Y. and Dai, J. (2021). Non-coplanar volumetric modulated arc therapy for locoregional radiotherapy of left-sided breast cancer including internal mammary nodes. Radiology and Oncology, 55(4), pp.499–507. doi:https://doi.org/10.2478/raon-2021-0045.

[7] A, B., et al. (2023). Dosimetric Comparision of Coplanar versus Non-coplanar Volumetric Modulated Arc Therapy for Treatment of Bilateral Breast Cancers. Journal of medical physics, [online] 48(3). doi:https://doi.org/10.4103/jmp.jmp_36_23.

[8] Biau J, Lopez L, Thivat E, Casile M, Millardet C, Saroul N, Pham-Dang N, Molnar I, Bourhis J, Lapeyre M. Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017-03 phase 2 trial. Clin Transl Radiat Oncol. 2022 Nov 14;38:169-174. doi: 10.1016/j.ctro.2022.11.07. PMID: 36466746; PMCID: PMC9712819.

[9]Woods KE, Ma TM, Cook KA, Morris ED, Gao Y, Sheng K, Kishan AU, Hegde JV, Felix C, Basehart V, Narahara K, Shen Z, Tenn S, Steinberg ML, Chin RK, Cao M. A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes. Cancers (Basel). 2022 Feb 14;14(4):939. doi: 10.3390/cancers14040939. PMID: 35205686; PMCID: PMC8870161.

[10] Gayen S, Kombathula SH, Manna S, Varshney S, Pareek P. Dosimetric comparison of coplanar and non-coplanar volumetric-modulated arc therapy in head and neck cancer treated with radiotherapy. Radiat Oncol J. 2020 Jun;38(2):138-147. doi: 10.3857/roj.2020.00143. Epub 2020 May 26. PMID: 33012157; PMCID: PMC7533406.

[11] Gayen S, Kombathula SH, Manna S, Varshney S, Pareek P. Dosimetric comparison of coplanar and non-coplanar volumetric-modulated arc therapy in head and neck cancer treated with radiotherapy. Radiat Oncol J. 2020 Jun;38(2):138-147. doi: 10.3857/roj.2020.00143. Epub 2020 May 26. PMID: 33012157; PMCID: PMC7533406.

[12] Subramanian VS, Subramani V, Chilukuri S, Kathirvel M, Arun G, Swamy ST, Subramanian K, Fogliata A, Cozzi L. Multi-isocentric 4π volumetric-modulated arc therapy approach for head and neck cancer. J Appl Clin Med Phys. 2017 Sep;18(5):293-300. doi: 10.1002/acm2.12164. Epub 2017 Aug 20. PMID: 28834021; PMCID: PMC5874945.

[13] Wild, E., Bangert, M., Nill, S. and Oelfke, U. (2015). Non-coplanar VMAT for nasopharyngeal tumors: Plan quality versus treatment time. Medical Physics, 42(5), pp.2157–2168. doi:https://doi.org/10.1118/1.4914863.

[14] Rossi L, Cambraia Lopes P, Marques Leitão J, Janus C, van de Pol M, Breedveld S, Penninkhof J, Heijmen BJM. On the Importance of Individualized, Non-Coplanar Beam Configurations in Mediastinal Lymphoma Radiotherapy, Optimized With Automated Planning. Front Oncol. 2021 Apr 15;11:619929. doi: 10.3389/fonc.2021.619929. PMID: 33937025; PMCID: PMC8082440.

[15]  Chen X, Jin D, Wang S, Li M, Huang P, Dai J. Non-coplanar intensity-modulated radiation therapy for young female patients with mediastinal lymphoma. J Appl Clin Med Phys. 2012 Nov 8;13(6):3769. doi: 10.1120/jacmp.v13i6.3769. PMID: 23149772; PMCID: PMC5718536.

[16] Yu VY, Landers A, Woods K, Nguyen D, Cao M, Du D, Chin RK, Sheng K, Kaprealian TB. A Prospective 4π Radiation Therapy Clinical Study in Recurrent High-Grade Glioma Patients. Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):144-151. doi: 10.1016/j.ijrobp.2018.01.048. Epub 2018 Jan 31. PMID: 29619962.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/raysearch-laboratories-and-vision-rt-present-innovations-in-surface-guided-treatment-planning-at-est,c4144768

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/raysearch-laboratories-and-vision-rt-present-innovations-in-surface-guided-treatment-planning-at-estro-302445457.html

SOURCE RaySearch Laboratories

Blockwave Exchange enhances its competitive edge by combining advanced security protocols, diversified trading tools, and a commitment to regulatory alignment in a dynamic digital asset environment.

SAN DIEGO, May 3, 2025 /PRNewswire-PRWeb/ — Blockwave Exchange, a rising digital asset trading platform, today unveiled a comprehensive update to its core infrastructure and service model, signaling a bold step forward in its mission to deliver a secure, transparent, and accessible cryptocurrency trading experience for global users. Amid intensifying competition in the digital finance sector, Blockwave’s latest strategic initiatives position the platform as a trusted partner for both retail and institutional participants.

Built around the pillars of simplicity, security, and performance, Blockwave Exchange offers a robust suite of trading services that include spot, margin, futures, and OTC (over-the-counter) capabilities. The platform supports a broad array of digital assets, ranging from established cryptocurrencies to promising emerging tokens.

Security-First Architecture for Market Confidence

Blockwave Exchange has prioritized security and compliance as the foundation of its operations. The platform incorporates multi-signature wallets, military-grade encryption, and routine third-party security audits. These measures are complemented by real-time transaction monitoring systems and strict internal controls designed to prevent unauthorized access and ensure uninterrupted service.

The exchange also adheres to stringent compliance protocols, including know-your-customer (KYC) and anti-money laundering (AML) procedures, ensuring its operations meet international regulatory standards and mitigate financial risks.

Intuitive Design and Scalable Trading Infrastructure

Designed with traders of all experience levels in mind, Blockwave features a clean, responsive user interface that simplifies complex operations. Real-time data feeds, customizable charting tools, and advanced order types allow users to make informed decisions quickly and efficiently. The platform supports cross-device trading across desktops and mobile devices, ensuring uninterrupted access to markets at all times.

Additionally, a knowledge hub offering tutorials, trading guides, and market insights enables users to deepen their understanding of digital assets and platform functionality.

Diverse Products and Tailored Trading Solutions

In response to growing market sophistication, Blockwave Exchange has expanded its offerings to include leveraged trading and institutional-grade OTC services. These features are designed to meet the needs of users seeking customized execution, high liquidity, and minimal slippage.

The exchange’s asset coverage includes Bitcoin, Ethereum, and other top-tier cryptocurrencies, as well as new listings reviewed through a rigorous vetting process. This ensures the availability of both established and innovative investment opportunities on a single platform.

Global Support and Community Education

Blockwave Exchange operates a 24/7 multilingual support team and maintains active communication channels to provide timely assistance and feedback. The platform also organizes webinars, market briefings, and security awareness campaigns to promote responsible trading habits and community engagement.

This educational commitment is aimed at equipping users with the tools and knowledge to navigate the evolving digital asset landscape safely and successfully.

Strategic Vision for Industry Leadership

Looking forward, Blockwave Exchange plans to expand into additional jurisdictions, enhance cross-chain interoperability, and integrate artificial intelligence-driven analytics to further empower its users. The platform is also actively participating in international regulatory forums and advocacy groups to help shape transparent standards for the industry’s future.

By staying at the forefront of innovation and compliance, Blockwave Exchange is poised to play a defining role in the next wave of global cryptocurrency adoption.

For more insights, visit Blockwave Exchange Website.

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities.

Media Contact

David Reynolds, Blockwave, 1 619-887-0841, service@blockwaveinc.com, https://blockwaveinc.com/

View original content to download multimedia:https://www.prweb.com/releases/blockwave-exchange-expands-global-reach-with-user-centric-platform-and-industry-leading-security-measures-302443778.html

SOURCE Blockwave Exchange